NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries

  • Written by ACN Newswire

image

TOKYO, Mar 31, 2021 - (JCN Newswire) - KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a license agreement for development and distribution of vibegron, a therapeutic agent for overactive bladder, in four ASEAN (Association of Southeast Asian Nations) member states; Thailand, the...

Read more: KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of...